Dr. Christopher Navas, MD

Dr. Navas practices at Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida.

Dr. Navas' NPI, 1861846081, was assigned on April 14, 2016. Dr. Navas graduated from Geisel School Of Medicine At Dartmouth in 2016. Dr. Navas holds Florida license ME155337.

Dr. Navas' primary practice is Jacksonville Center for Endoscopy - Southside, at 4800 Belfort Rd, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 265-4801.

Dr. Navas' primary practice is Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida. Dr. Navas is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Borland Groover. Dmand AI also links Dr. Navas to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Navas practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Navas' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Navas is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Navas' licenses on file in 3 states: Florida, New Hampshire and Vermont.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Navas treats.

CMS data shows 1,360 Medicare services from Dr. Navas across 18 procedure codes in 2024, for 618 Medicare patients. Medicare paid $128,483 for them.

CMS counts 618 Medicare patients who saw Dr. Navas in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Navas' median patient age at 57, with 55% women.

In 2024, Dr. Navas wrote 532 Medicare Part D claims for 204 patients. 75% of them were for generic drugs. CMS names the drug for 333 of them, across 9 drugs with 11 or more claims each, at $404,619 in total drug cost. In 2023, CMS named 194 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Navas for performance year 2024, reported as part of a group. Dr. Navas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Navas as offering telehealth. CMS counts 155 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Navas, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Navas, published from 2017 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Gastroparesis, Constipation and Defecation. Dr. Navas has published most often in Clin Gastroenterol Hepatol. Dr. Navas' most frequent co-authors are Brian E. Lacy, MD, PhD, William D. Chey, MD and Nayla Ahmed, MBBS, MD.

CMS Open Payments shows 144 general payments to Dr. Navas from 25 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $723.

Dr. Navas graduated from Geisel School Of Medicine At Dartmouth in 2016.

Dr. Navas is in network with 21 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.